Vascular Imaging Market is expected to reach USD 5.95 billion by 2022

LONDON, June 14, 2017 /PRNewswire/ -- Highlights ·         Vascular imaging market projected to grow at a CAGR of 6.5% ·         The global vascular imaging market is expected to reach USD 5.95 billion by 2022, at a CAGR of 6.5% from 2017 to 2022. ·         The major factors driving this market are the rising incidence and prevalence of CVDs, growing aging population, and technological innovations in vascular imaging systems. ·         On the other hand, the growth of this market is restrained to some extent due to the accessibility of conventional low-cost alternates to treat CVDs. ·         Magnetic Resonance Imaging to register the highest CAGR during the forecast period ·         On the basis of technique, the market is segmented into MRI, CT, ultrasound, nuclear imaging, and X-ray. ·         The MRI segment is expected to register the highest growth during the forecast period. This is attributed to the increasing incidence of CVDs and the launch of advanced MRI systems. ·         Hospitals to dominate the vascular imaging market during the forecast period ·         Based on end user, the market has been segmented into hospitals, diagnostic imaging centers, and other end users. ·         Hospitals are the largest end users of vascular imaging systems. ·         It is also is estimated to register the highest growth. ·         This can be attributed to technological development, increasing healthcare expenditure, and increasing use of imaging systems in hospitals and hybrid ORs, particularly in developed countries across North America and Europe. ·         Asia is estimated to be the fastest growing regional segment in the global vascular imaging market during the forecast period "Vascular imaging market projected to grow at a CAGR of 6.5%" The global vascular imaging market is expected to reach USD 5.95 billion by 2022, at a CAGR of 6.5% from 2017 to 2022. The major factors driving this market are the rising incidence and prevalence of CVDs, growing aging population, and technological innovations in vascular imaging systems. On the other hand, the growth of this market is restrained to some extent due to the accessibility of conventional low-cost alternates to treat CVDs. "Magnetic Resonance Imaging to register the highest CAGR during the forecast period" On the basis of technique, the market is segmented into MRI, CT, ultrasound, nuclear imaging, and X-ray. The MRI segment is expected to register the highest growth during the forecast period. This is attributed to the increasing incidence of CVDs and the launch of advanced MRI systems. "Hospitals to dominate the vascular imaging market during the forecast period" Based on end user, the market has been segmented into hospitals, diagnostic imaging centers, and other end users. Hospitals are the largest end users of vascular imaging systems. It is also is estimated to register the highest growth. This can be attributed to technological development, increasing healthcare expenditure, and increasing use of imaging systems in hospitals and hybrid ORs, particularly in developed countries across North America and Europe. "Asia is estimated to be the fastest growing regional segment in the global vascular imaging market during the forecast period" Geographically, the market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). The Asian market is estimated to register the highest growth, which can be attributed to the increasing expenditure in healthcare, growing penetration of health insurance, and rise in disposable incomes especially in countries like China, Japan, and India. The key players in the market are Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Fujifilm SonoSite (Japan), Hologic, Inc. (U.S.), Esaote SpA (Italy), Carestream Health, Inc. (U.S.), Konica Minolta (Japan), Alpinion Medical Systems (South Korea), Pie Medical Imaging (Netherlands), CorVascular Diagnostics LLC (U.S.), Evena Medical, Inc. (U.S.), LumedX Healthcare Technologies (U.S.), Xograph Healthcare (U.K.), Mindray Medical International Ltd. (China), Novadaq Technologies Inc. (Canada), Omega Medical Imaging LLC. (U.S.), BK Ultrasound (U.S.), and Piur imaging GmbH (Austria). The report provides insights on the following pointers: • Market Penetration: Comprehensive information on the product portfolios of the top players in the vascular imaging market • Product Development/Innovation: Detailed insights on the upcoming technologies, R&D activities, and product launches in the vascular imaging market • Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the vascular imaging market • Market Development: Comprehensive information about emerging markets. This report analyses the market for various vascular imaging market across geographies • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the vascular imaging market Download the full report: https://www.reportbuyer.com/product/4937593/ About Reportbuyer Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers http://www.reportbuyer.com   For more information: Sarah Smith Research Advisor at Reportbuyer.com Email: [email protected]

Advertisement

Tel: +44 208 816 85 48 Website: www.reportbuyer.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vascular-imaging-market-is-expected-to-reach-usd-595-billion-by-2022-300474078.html

SOURCE ReportBuyer